The United States Department of Agriculture (USDA) has awarded $2 million to a team of Georgia Tech and Georgia Tech Research Institute (GTRI) researchers to develop a first-of-its-kind vaccine pill for bird flu.
For decades, bird flu was uncommon in the U.S., but that has changed. In the past several years, epidemics have threatened poultry and dairy cattle operations across the country. Higher egg prices, driven largely by bird flu-related supply disruptions, have cost American consumers billions of dollars in losses.
“The H5N1 strain of the bird flu, which has driven recent and current outbreaks, is a highly lethal virus that kills domestic chickens and other bird species in droves,” said David Pattie, GTRI research scientist and branch chief. “It can easily jump from birds to other animal species — and sometimes to humans.”
The research team will leverage artificial intelligence (AI) to design and test a probiotic avian flu vaccine that, if successful, could be served to chickens in their feed. Currently, vaccinating a flock means individually injecting every bird.
“We’re focusing on live bacterial vaccines, which means the vaccine comes from living bacteria you swallow, instead of an injection,” said Mike Farrell, GTRI principal research scientist and the project’s lead investigator.
Source : gatech.edu